Adaptimmune is a leader in the development of T-cell-based therapies for the treatment of cancer. Adaptimmune has programmes in clinical trials as well as an exciting pipeline of new targets. At Adaptimmune, our team is driven by a core goal: That together we can change the way certain cancers are treated, and bring important new T-cell based therapeutics to patients in need.
Based just outside Oxford, UK, Adaptimmune offers the opportunity to take part in pioneering the development of T-cell therapy. The company has an inventive and collaborative culture, where employees are valued and inspired as well as rewarded for their ideas and contributions. The organisation of research in Adaptimmune has created an environment where it is possible to make both individual and team contributions towards scientific excellence.